earticle

논문검색

특집 : 식품효소 - 연구논문

동물 및 인체시험을 통한 Nattokinase의 항응고 작용 및 섬유소 용해능 평가

원문정보

Evaluation of Nattokinase for Antithrombotic Effect and Pharmacological Efficacy by a Biological Test and Clinical Trial

김재범, 유철배, 신현만, 정준기, 장형욱

피인용수 : 0(자료제공 : 네이버학술정보)

초록

영어

Bacillus subtilis natto producing high level of a fibrinolytic enzyme was selected and Ultra NattokinaseⓇ was manufactured by fermentation and purification. It was performed the evaluation of the antithrombotic effect of Ultra NattokinaseⓇ (20,000 FU/g) with rat blood plasma. The maximum aggregation (inhibition ratio) was 71% (0%), 69% (2.8%), 62% (12.7%), 16% (77.5%) and 9% (87.3%), respectively, in the order of 0, 5, 10, 50 and 100 mg/mL of Ultra NattokinaseⓇ solutions. Ultra NattokinaseⓇ had antithrombotic effect, which was associated with the suppression of collageninduced platelet aggregation. Ultra NattokinaseⓇ in the topic of the FDP (fibrinogen degradation products) in blood coagulation tests showed a significant increasing trend. And based on the daily record of meal 39 people of ITT (what ?) group consisted with 19 people of NP (what ?) group and 20 people of PN (what ?) group except four people, two people who took vitamin K affecting the experiment and two people who took alcohol, finding to be taken Ultra NattokinaseⓇ showed an increase in the FDP value after four weeks. In addition, FDP value of 41 people of ITT group except two people having metabolic syndrome was increased by Ultra NattokinaseⓇ.

목차

Abstract
 1. 서론
 2. 재료 및 방법
  2.1. 재료
  2.2. 균주 선별
  2.3. 발효 및 제품제조
  2.4. 동물 시험 방법
  2.5. 인체 시험 방법
 3. 결과 및 고찰
  3.1. 균주 선별 및 제품 제조
  3.2. 랫드를 이용한 Ultra NattokinaseⓇ의 혈액 응고에 미치는 영향 검정
  3.3. 정상인 또는 대사 증후군에게 Ultra NattokinaseⓇ를 경구투여하였을 때 혈액 응고계에 미치는 영향 평가
  3.4. 기저 시점 대비 복용 후 4주에서의 혈액 응고 검사 항목별 변화량, ITT군
  3.5. 기저 시점 대비 복용 후 4주에서의 혈액 응고 검사 항목별 변화량, PP군
  3.6. 식이섭취에 따른 유효성 분석
  3.7. 대사 증후군 피험자 제외 유효성 분석
  3.8. 이상 반응 발현률
 4. 결론
 감사
 References

저자정보

  • 김재범 Jae-Bum Kim. 케이피엑스바이오텍(주)
  • 유철배 Chul-Bae Yoo. 케이피엑스바이오텍(주)
  • 신현만 Hyun-Man Shin. 케이피엑스바이오텍(주)
  • 정준기 Joon-Ki Jung. 한국생명공학연구원
  • 장형욱 Hyung-Wook Jang. 케이피엑스바이오텍(주)

참고문헌

자료제공 : 네이버학술정보

    함께 이용한 논문

      ※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.

      0개의 논문이 장바구니에 담겼습니다.